GGrantIndex
← Leaderboards

Stephen E Gitelman

University Of California San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$12,344,642
Attributed
$12,898,567
Total exposure
13
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,898,567 · 13

By mechanism

U01$8,100,970 · 1
T32$2,838,482 · 1
K12$1,735,655 · 1
M01$223,460 · 10

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchChildhoodInsulinHuman SubjectUniversitiesCaliforniaSan FranciscoRecruitment ActivityProgramsDiabetes MellitusResearch PersonnelEndocrinologyTranslational ResearchInsulin-Dependent Diabetes MellitusInstitutesTraining ProgramsClinical SciencesHuman Therapy EvaluationAutoimmune ProcessBeta CellBasic ScienceProtocols DocumentationFundingHypoglycemia

Grant awards (54)

Training Program in Pediatric Endocrinology$304,981
T32 · FY2025 · DK · contact PI
Training Program in Pediatric Endocrinology$270,673
T32 · FY2024 · DK · contact PI
Training Program in Pediatric Endocrinology$271,384
T32 · FY2023 · DK · contact PI
Training Program in Pediatric Endocrinology$260,813
T32 · FY2022 · DK · contact PI
Training Program in Pediatric Endocrinology$241,826
T32 · FY2020 · DK · contact PI
Training Program in Pediatric Endocrinology$222,300
T32 · FY2019 · DK · contact PI
Continuation of UCSF as a Clinical Center for TrialNet$693,225
U01 · FY2018 · DK · contact PI
Training Program in Pediatric Endocrinology$217,654
T32 · FY2018 · DK · contact PI
Continuation of UCSF as a Clinical Center for TrialNet$479,692
U01 · FY2017 · DK · contact PI
Training Program in Pediatric Endocrinology$194,714
T32 · FY2017 · DK · contact PI
Continuation of UCSF as a Clinical Center for TrialNet$479,692
U01 · FY2016 · DK · contact PI
Training Program in Pediatric Endocrinology$153,135
T32 · FY2016 · DK · contact PI
Continuation of UCSF as a Clinical Center for TrialNet$479,692
U01 · FY2015 · DK · contact PI
K12 In Diabetes (KIDS)$354,974
K12 · FY2015 · DK · contact PI
Training Grant in Pediatric Endocrinology$206,553
T32 · FY2015 · DK · contact PI
Continuation of UCSF as a Clinical Center for TrialNet$685,251
U01 · FY2014 · DK · contact PI
K12 In Diabetes (KIDS)$386,259
K12 · FY2014 · DK · contact PI
Training Grant in Pediatric Endocrinology$249,412
T32 · FY2014 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$26,868
U01 · FY2014 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$659,215
U01 · FY2013 · DK · contact PI
Training Grant in Pediatric Endocrinology$245,037
T32 · FY2013 · DK · contact PI
K12 In Diabetes (KIDS)$211,118
K12 · FY2013 · DK · contact PI
K12 In Diabetes (KIDS)$390,728
K12 · FY2012 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$290,445
U01 · FY2012 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$744,830
U01 · FY2011 · DK · contact PI
K12 In Diabetes (KIDS)$392,576
K12 · FY2011 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$776,135
U01 · FY2010 · DK · contact PI
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes$702,985
U01 · FY2009 · DK · contact PI
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$863,786
U01 · FY2007 · DK · contact PI
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$1
U01 · FY2006 · DK · contact PI
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$114,845
U01 · FY2005 · DK
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$71,924
M01 · FY2005 · RR
A MULTICENTER, RANDOMIZED DOUBLE BLIND TRIAL OF METFORMIN IN OBESE ADOLESCENTS$17,981
M01 · FY2005 · RR
T CELL ASSAYS IN TYPE 1 DIABETES MELLITUS$15,412
M01 · FY2005 · RR
IMMUNE TOLERANCE NETWORK PILOT 2 PROTOCOL NO LPL12$7,706
M01 · FY2005 · RR
USE OF CONTINUOUS GLUCOSE MONITORING IN INFANTS AND CHILDREN WITH HYPOGLYCEMIA$7,340
M01 · FY2005 · RR
PILOT STUDY ON THE EFFECT OF ORAL ALPHA-LIPOIC ACID ON OXIDATIVE STRESS IN T1DM$6,239
M01 · FY2005 · RR
THE TYPE 1 DIABETES GENETICS CONSORTIUM PROTOCOL$5,871
M01 · FY2005 · RR
HOKTT3YL (ALA ALA) IN PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS$3,303
M01 · FY2005 · RR
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$276,380
U01 · FY2004 · DK
hOKTT3yl (ala ala) in participants with type 1 diabetes mellitus$28,166
M01 · FY2004 · RR
Use of continuous glucose monitoring in infants and children with hypoglycemia$19,835
M01 · FY2004 · RR
Immune tolerance network pilot 2 protocol no. LPL12$5,950
M01 · FY2004 · RR
A multicenter, randomized double blind trial of metformin in obese adolescents$3,570
M01 · FY2004 · RR
Measurement of insulin secretory response to a mixed meal in normal individuals$2,380
M01 · FY2004 · RR
T cell assays in Type 1 diabetes mellitus$1,984
M01 · FY2004 · RR
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$266,390
U01 · FY2003 · DK
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$281,874
U01 · FY2002 · DK
CRF IN THE DIAGNOSIS AND LONGTERM MANAGEMENT OF PEDIATRIC CUSHING'S DISEASE$0
M01 · FY2002 · RR
UCSF TrialNet: A Phase II Trial of hokT3gamma1 (Ala-Ala)$279,664
U01 · FY2001 · DK
CRF IN THE DIAGNOSIS AND LONGTERM MANAGEMENT OF PEDIATRIC CUSHING'S DISEASE$0
M01 · FY2001 · RR
CRF IN THE DIAGNOSIS AND LONGTERM MANAGEMENT OF PEDIATRIC CUSHING'S DISEASE$25,799
M01 · FY2000 · RR
CRF IN THE DIAGNOSIS AND LONGTERM MANAGEMENT OF PEDIATRIC CUSHING'S DISEASE$0
M01 · FY2000 · RR
CRF IN THE DIAGNOSIS AND LONGTERM MANAGEMENT OF PEDIATRIC CUSHING'S DISEASE$0
M01 · FY2000 · RR